P170030S022

None

FDA Premarket Approval P170030 S022

This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.

Pre-market Approval Supplement Details

DeviceP170030S022
Classification NameNone
Applicant
PMAP170030
SupplementS022

Supplemental Filings

Supplement NumberDateSupplement Type
P170030Original Filing
S026 2022-07-07 30-day Notice
S025
S024 2022-06-21 30-day Notice
S023
S022
S021 2022-01-31 30-day Notice
S020 2021-11-09 30-day Notice
S019
S018 2021-07-02 30-day Notice
S017 2021-06-14 30-day Notice
S016 2021-04-08 30-day Notice
S015 2021-03-25 30-day Notice
S014 2021-01-19 30-day Notice
S013 2020-10-16 30-day Notice
S012 2020-10-16 30-day Notice
S011 2020-10-02 Normal 180 Day Track No User Fee
S010 2020-09-21 30-day Notice
S009
S008 2020-07-22 30-day Notice
S007
S006 2020-06-02 30-day Notice
S005 2019-11-04 30-day Notice
S004 2019-09-27 30-day Notice
S003 2019-04-17 Normal 180 Day Track No User Fee
S002
S001

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.